Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy

• Mayank Verma,

  Roles Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Writing – original draft

  Affiliations Medical Scientist Training Program, University of Minnesota Medical School, Minneapolis, MN, United States of America, Stem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, United States of America, Paul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, United States of America, Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, United States of America

  http://orcid.org/0000-0003-0167-0842

  ⨯
• Yuko Shimizu-Motohashi,

  Roles Data curation, Formal analysis, Investigation

  Affiliations Stem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, United States of America, Paul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, United States of America, Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, United States of America

  ⨯
• Yoko Asakura,

  Roles Data curation, Formal analysis, Investigation

  Affiliations Stem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, United States of America, Paul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, United States of America, Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, United States of America

  http://orcid.org/0000-0003-4107-4236

  ⨯
• James P. Ennen,

  Roles Data curation, Investigation

  Affiliations Stem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, United States of America, Paul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, United States of America, Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, United States of America

  http://orcid.org/0000-0003-1600-3380

  ⨯
• Jennifer Bosco,

  Roles Formal analysis, Investigation

  Affiliation Shire Human Genetic Therapies, Inc., a member of the Takeda group of companies, Lexington, MA, United States of America

  ⨯
• Zhiwei Zhou,

  Roles Formal analysis, Investigation

  Affiliation Shire Human Genetic Therapies, Inc., a member of the Takeda group of companies, Lexington, MA, United States of America

  http://orcid.org/0000-0002-9467-6241

  ⨯
• Guo-Hua Fong,

  Roles Resources

  Affiliation Center for Vascular Biology, University of Connecticut Health Center, University of Connecticut School of Medicine, Farmington, CT, United States of America

  ⨯
• Serene Josiah,

  Roles Project administration, Resources

  Affiliation Shire Human Genetic Therapies, Inc., a member of the Takeda group of companies, Lexington, MA, United States of America

  ⨯
• Dennis Keefe,

  Roles Formal analysis, Project administration, Resources

  Affiliation Shire Human Genetic Therapies, Inc., a member of the Takeda group of companies, Lexington, MA, United States of America

  ⨯
• Atsushi Asakura

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Resources, Supervision, Validation, Writing – review & editing

  * E-mail: asakura@umn.edu

  Affiliations Stem Cell Institute, University of Minnesota Medical School, Minneapolis, MN, United States of America, Paul & Sheila Wellstone Muscular Dystrophy Center, University of Minnesota Medical School, Minneapolis, MN, United States of America, Department of Neurology, University of Minnesota Medical School, Minneapolis, MN, United States of America

  http://orcid.org/0000-0001-8078-1027

  ⨯